Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 11 recruiting now early-phase tilt

Subarachnoid Hemorrhage: early-phase trial registry

11 of 22 indexed Subarachnoid Hemorrhage trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #756 of 28,707 conditions by registered trial count.

22 US clinical trials · 11 currently recruiting · #756 of 28,707 conditions by registered trial count

Subarachnoid Hemorrhage: 22 US clinical trials tracked, 11 recruiting.

Subarachnoid Hemorrhage is the subject of 22 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is University of Maryland, Baltimore, running 3 of these trials.

Enrollment posture brief

Registry condition subarachnoid-hemorrhage

OPEN 11 | RECR 50% | LATE 2 | EARLY 5 | RANK #756 | SPON 3

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Advanced Melanoma63.6%Subarachnoid Hemorrhage (thi…50%Acute Myeloid Leukemia Arisi18.2%Adenocarcinoma of the Prosta0%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Subarachnoid Hemorrhage

Subarachnoid Hemorrhage lists 11 open slots (50% of 22 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Subarachnoid Hemorrhage on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Subarachnoid Hemorrhage is recruiting above its size-band peers.

    11 of 22 indexed trials (50%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Subarachnoid Hemorrhage trials is spread across many organizations.

    University of Maryland, Baltimore accounts for 3 of 22 trials (13.6%). 19 distinct sponsors appear on at least one study for this condition label.

  3. Typical Subarachnoid Hemorrhage enrolment sits around 100 participants.

    Median target enrolment is 100 among the 22 trials that report a genuine target (sentinel values excluded). 11 of those (50%) plan for fewer than 100 participants.

  4. Subarachnoid Hemorrhage splits between interventional and observational designs.

    13 interventional and 9 observational studies make up this index (59.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 15Phase 42

Open and recent trials

22 total, page 1 of 1

RECRUITING 60,000 participants

Stroke Recovery Initiative - Registry for Stroke Research Studies

University of California, San Francisco

NCT03318432

RECRUITING 8,000 participants

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

Massachusetts General Hospital

NCT04916210

RECRUITING 5,000 participants

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

University of Maryland, Baltimore

NCT04189471

RECRUITING NA 240 participants

AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis

Ohio State University

NCT05649904

RECRUITING NA 100 participants

Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage

University of California, San Diego

NCT03065231

RECRUITING Phase 1 84 participants

Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?

Montefiore Medical Center

NCT05001750

RECRUITING NA 50 participants

Auricular VNS Following Subarachnoid Hemorrhage

Anna Huguenard

NCT04557618

RECRUITING 50 participants

Optical Coherence Tomography Angiography in Neurological Disease

University of Texas Southwestern Medical Center

NCT06797765

RECRUITING 50 participants

Effect of the Stellate Ganglion Block on the Retinal Microcirculation

University of Texas Southwestern Medical Center

NCT06797752

RECRUITING NA 30 participants

Impact of NMES and HPRO on Recovery After SAH- Pilot Study

University of Maryland, Baltimore

NCT03201094

RECRUITING Phase 1 15 participants

Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury

University of Maryland, Baltimore

NCT06103201

ACTIVE NOT RECRUITING 150 participants

Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage

Vanderbilt University Medical Center

NCT00593268

COMPLETED Phase 4 447 participants

PRET: Patients Prone to Recurrence After Endovascular Treatment

Centre hospitalier de l'Université de Montréal (CHUM)

NCT00626912

COMPLETED Phase 4 434 participants

Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System

Codman & Shurtleff

NCT00197392

COMPLETED NA 260 participants

Cerebral Perfusion Pressure (CPP) Management Information Feedback and Nursing

University of Washington

NCT00194441

COMPLETED 163 participants

Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

University of Illinois at Chicago

NCT00490464

COMPLETED Phase 1 104 participants

A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm

Brigham and Women's Hospital

NCT00235963

COMPLETED Phase 1 60 participants

Subarachnoid Hemorrhage Recovery And Galantamine

The University of Texas Health Science Center, Houston

NCT02872857

COMPLETED 50 participants

Identification of Novel Molecular Markers for Vasospasm

St. Joseph's Hospital and Medical Center, Phoenix

NCT02389634

COMPLETED NA 30 participants

Early Intensive Physical Therapy in Subarachnoid Hemorrhage

University of Colorado, Denver

NCT02675985

COMPLETED Phase 1 20 participants

Remote Ischemic Preconditioning in Subarachnoid Hemorrhage

University of California, Los Angeles

NCT01158508

COMPLETED 7 participants

Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage

University of Cincinnati

NCT01406457

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 4 2

Named interventions

Most-linked intervention names on Subarachnoid Hemorrhage records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Nicardipine and Nipride Drug
1 trials
12mg galantamine twice daily Drug
1 trials
8mg galantamine twice daily Drug
1 trials
Standard EVD Catheter Device
1 trials
Bactiseal TM EVD Device
1 trials
Remote ischemic preconditioning Procedure
1 trials
Bedside display of cerebral perfusion pressure information Other
1 trials
endovascular coil embolization Procedure
1 trials

US sites by state

Facility locations filed on Subarachnoid Hemorrhage trials. A trial with sites in several states counts in each.

California 5 trials
Texas 4 trials
New York 4 trials
Maryland 4 trials
Ohio 3 trials
Florida 3 trials
Mississippi 2 trials
Missouri 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Subarachnoid Hemorrhage page

22 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Subarachnoid Hemorrhage condition card totals 22 registered trials; most-linked intervention Nicardipine and Nipride; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.